KATZ STEVEN C (Chief Medical Officer) received a stock award from TRISALUS LIFE SCIENCES, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/14/2024ACC: 0001415889-24-003799
Officer· Chief Medical Officer
Since Aug 2023
+139.14K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
139.14K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+34.14K
Price / share
—
Trade value
—
% of position
99.1%
2/12/2024
34.44K→68.59K
Total
Net shares
+34.14K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/12/2024 | A · Award | +34.14K | — | — | 99.1% | 34.44K | 68.59K |
| Total | +34.14K | $0.00 | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
105K shares
Shares
+105K
Strike price
9.50
Held after
105K
Exercisable
—
2/12/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock105K shares | 2/12/2024 | A · Award | +105K | 9.50 | — | 105K |